Location: Seoul, Korea, Republic of
CIK: 0001710065 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 9, 2022
Total Value: $71.78M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYMR | KYMERA THERAPEUTICS INC | 457,059 | $29.02M | 40.4% | $48.78 | +19.4% | COM | 501575104 |
| SEER | SEER INC | 816,375 | $18.62M | 25.9% | $63.62 | -54.7% | COM CL A | 81578P106 |
| XLO | XILIO THERAPEUTICS INC | 667,742 | $10.68M | 14.9% | $17.03 | 0.0% | COM | 98422T100 |
| — | RALLYBIO CORP | 754,678 | $7.2M | 10.0% | $9.54 | — | COM | 75120L100 |
| — | RAPT THERAPEUTICS INC | 99,503 | $3.655M | 5.1% | $19.75 | — | COM | 75382E109 |
| — | SUTRO BIOPHARMA INC | 175,000 | $2.604M | 3.6% | $21.71 | — | COM | 869367102 |